Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

× No keyword cloud information.

142 in total

1. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?

Authors: S J Smith; N D Markandu; G A Sagnella; G A MacGregor
Journal: Br Med J (Clin Res Ed) Date: 1985-01-12

2. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.

Authors: J J Curtis; R G Luke; J D Whelchel; A G Diethelm; P Jones; H P Dustan
Journal: N Engl J Med Date: 1983-02-17 Impact factor: 91.245

3. Why do we need some large, simple randomized trials?

Authors: S Yusuf; R Collins; R Peto
Journal: Stat Med Date: 1984 Oct-Dec Impact factor: 2.373

4. Combined modality therapy of cancer. What is it and when does it work?

Authors: S A Rosenberg
Journal: N Engl J Med Date: 1985-06-06 Impact factor: 91.245

5. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors: A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal: Lancet Date: 1985-06-15 Impact factor: 79.321

6. Is borderline fasting hyperglycemia a risk factor for cardiovascular death?

Authors: E Barrett-Connor; D L Wingard; M H Criqui; L Suarez
Journal: J Chronic Dis Date: 1984

7. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial.

Authors: L O Watkins; J D Neaton; L H Kuller
Journal: Am J Cardiol Date: 1986-03-01 Impact factor: 2.778

8. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study.

Authors: P Degoulet; M Legrain; I Réach; F Aimé; C Devriés; P Rojas; C Jacobs
Journal: Nephron Date: 1982 Impact factor: 2.847

9. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction.

Authors: L E Daly; R Mulcahy; I M Graham; N Hickey
Journal: Br Med J (Clin Res Ed) Date: 1983-07-30

10. Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration.

Authors: P N Durrington
Journal: Clin Chim Acta Date: 1980-05-21 Impact factor: 3.786

99 in total

1. Cholesterol lowering margarine may not be useful in healthy fat modified diet.

Authors: C van Heyningen
Journal: BMJ Date: 1999-07-17

2. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors: E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal: BMJ Date: 2000-03-11

10. Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice.

Authors: Q Wan; M F Harris; U W Jayasinghe; J Flack; A Georgiou; D L Penn; J R Burns
Journal: Qual Saf Health Care Date: 2006-04

Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

1. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?

2. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.

3. Why do we need some large, simple randomized trials?

4. Combined modality therapy of cancer. What is it and when does it work?

5. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

6. Is borderline fasting hyperglycemia a risk factor for cardiovascular death?

7. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial.

8. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study.

9. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction.

10. Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration.

1. Cholesterol lowering margarine may not be useful in healthy fat modified diet.

2. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

3. Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods.

4. Diabetes care needs evidence based interventions to reduce risk of vascular disease.

5. Treating dyslipidaemia in primary care. The gap between policy and reality is large in the UK.

6. National service framework for coronary heart disease. Ambiguities need to be clarified.

Review 7. Drugs used in secondary prevention after myocardial infarction: case presentation.

Review 8. Goals of statin therapy: three viewpoints.

9. Risk factor thresholds. Threshold is 37 000 pounds sterling per QALY.

10. Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice.